Associated Papers
A G316A Polymorphism in the Ornithine Decarboxylase Gene Promoter Modulates MYCN-Driven Childhood Neuroblastoma.
Gamble LD et al.
Cancers, 2021
Genetic polymorphisms as prognostic factors for recurrent kidney stones: A systematic review and meta-analysis.
Atmoko W et al.
Plos One, 2021
Interaction between polymorphisms in aspirin metabolic pathways, regular aspirin use and colorectal cancer risk: A case-control study in unselected white European populations.
Sheth H et al.
Plos One, 2018
29425227 (PubMed )
Supplement: pone.0192223.s005.docx
Lack of evidence for the association of ornithine decarboxylase (+316 G>A), spermidine/spermine acetyl transferase (-1415 T>C) gene polymorphisms with calcium oxalate stone disease.
Coker-Gürkan A et al.
Biomedical Reports, 2014
Ornithine decarboxylase G316A genotype and colorectal cancer risk.
Hughes DJ et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland, 2011
Associations of a polymorphism in the ornithine decarboxylase gene with colorectal cancer survival.
Zell JA et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2009
Genetic polymorphism in ornithine decarboxylase and risk of breast cancer.
Brown I et al.
Familial Cancer, 2009
Select a paper to view details